|
American Medical Association |
Precision Medicine for Your Practice: Exploring Somatic Cancer Panel Testing |
0.5 |
Yes |
11/17/2025 |
|
American Medical Association |
Precision Medicine for Your Practice: Genetic Testing in Pediatric Neurology |
0.5 |
Yes |
9/8/2025 |
|
American Medical Association |
Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual |
0.5 |
Yes |
1/5/2027 |
|
American Medical Association |
Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual |
0.5 |
Yes |
1/5/2027 |
|
American Medical Association |
Precision Medicine for Your Practice: Interpreting Results from Somatic Cancer Panel Testing |
0.5 |
Yes |
6/4/2024 |
|
American Medical Association |
Precision Medicine For Your Practice: Prenatal Cell-Free DNA Screening |
0.75 |
Yes |
8/21/2025 |
|
American Medical Association |
Precision Medicine For Your Practice: Prenatal Cell-Free DNA Screening |
0.5 |
Yes |
8/21/2025 |
|
JAMA Ophthalmology |
Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery |
1 |
Yes |
10/20/2024 |
|
JAMA Psychiatry |
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections |
1 |
Yes |
11/14/2025 |
|
JAMA |
Preexposure Prophylaxis for the Prevention of HIV - Updated Evidence Report and Systematic Review for the US Preventive Services Task Force |
1 |
Yes |
8/22/2024 |
|
JAMA |
Preexposure Prophylaxis to Prevent Acquisition of HIV - US Preventive Services Task Force Recommendation Statement |
1 |
Yes |
8/22/2024 |
|
JAMA Network Open |
Preferences for Alternative Care Modalities Among French Adults With Chronic Illness |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Preferences for Alternative Care Modalities Among French Adults With Chronic Illness |
1 |
Yes |
1/14/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Preliminary Analysis of Association Between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System Data |
1 |
Yes |
6/4/2024 |
|
JAMA |
Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring - The MAGENTA Randomized Clinical Trial |
1 |
Yes |
8/15/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Prescribing Controlled Substances |
2 |
Yes |
4/19/2026 |
|
JAMA |
Prescribing Opioids for Pain |
1 |
Yes |
4/24/2024 |
|
American Association for Physician Leadership |
Presentation Skills for Physician Leaders |
5.0 |
Yes |
10/30/2026 |
|
JAMA Ophthalmology |
Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19 |
1 |
Yes |
8/4/2024 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Preterm Birth: Prevention |
0.75 |
Yes |
5/18/2026 |
